4
Changes in Ownership
Werewolf Therapeutics, Inc. Filed Acc 0000950170-25-002344
Options or other derivatives
- Chief Financial Officer acquired 210,358 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Trost Timothy W. Chief Financial Officer | 2025-01-02 | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | D | ||
| Trost Timothy W. Chief Financial Officer | 2025-01-02 | Grant or award · Stock Option (right to buy) | +60,358 | 60,358 | D | ||
Loading xslF345X05/ownership.xml…